Mary Thistle Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mary Thistle.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mary Thistle. Mary Thistle is a Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and a Sr VP & GM Reproductive Health in VIACELL INC ($VIAC) and a Chief Business Officer in Dimension Therapeutics, Inc. ($DMTX) and a Chief Operating Officer in Dimension Therapeutics, Inc. ($DMTX) and a Director in Homology Medicines, Inc. ($FIXX).
Address: C/O VIACELL, INC. 245 FIRST STREET CAMBRIDGE 02142 MA
Companies in which Mary Thistle is an Insider
Dimension Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mary Thistle: Chief Operating Officer, Chief Business Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 07 2017
$DMTX Market Capitalization: $41.32M
$DMTX Previous Close: $1.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Homology Medicines, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary Thistle: Director
Holdings: 0 shares
Latest Transaction: Jun 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VIACELL INC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Mary Thistle: Sr VP & GM Reproductive Health
Holdings: 0 shares
Latest Transaction: Mar 03 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ZIOPHARM ONCOLOGY INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary Thistle: Director
Holdings: 5,000 shares
Current Value: $33,500
Latest Transaction: May 06 2021
$ZIOP Market Capitalization: $850.83M
$ZIOP Previous Close: $6.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mary Thistle
Sentiment: All, DMTX, FIXX, VIAC, ZIOP
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | FIXX | Homology Medicines ... | Thistle Mary | Director | Option Exercise | A | 7.26 | 18,000 | 130,680 | 18,000 | |
| May 06 2021 | ZIOP | ZIOPHARM ONCOLOGY ... | Thistle Mary | Director | Option Exercise | A | 4.31 | 150,000 | 646,500 | 150,000 | |
| May 06 2021 | ZIOP | ZIOPHARM ONCOLOGY ... | Thistle Mary | Director | Option Exercise | A | 4.31 | 37,500 | 161,625 | 37,500 | |
| May 06 2021 | ZIOP | ZIOPHARM ONCOLOGY ... | Thistle Mary | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Jun 12 2020 | FIXX | Homology Medicines ... | Thistle Mary | Director | Option Exercise | A | 16.32 | 18,000 | 293,760 | 18,000 | |
| Jun 10 2019 | FIXX | Homology Medicines ... | Thistle Mary | Director | Option Exercise | A | 19.51 | 15,580 | 303,966 | 15,580 | |
| Mar 29 2018 | FIXX | Homology Medicines ... | Thistle Mary | Director | Option Exercise | A | 16.00 | 31,160 | 498,560 | 31,160 |